
|Articles|January 1, 2004
Using aromatase inhibitors to induce ovulation in breast Ca survivors
The second installment in our two-part article on AIs looks at these agents as potential alternatives to clomiphene citrate and gonadotropins for stimulating fertility in breast cancer survivors.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Contemporary OB/GYN week in review: FemVue clearance, flibanserin approval, and more
2
GSK, Spero Therapeutics resubmits NDA for tebipenem HBr as oral option for complicated urinary tract infections
3
FDA clears FemVue Controlled for in-office tubal assessment
4
Late-stage cervical cancer risk higher in older women
5










